Skip to content
Screener

Bausch + Lomb BLCO Q3 2025 earnings

Reported October 29, 2025 · Before market open

Revenue$1.3BMiss by $102.4M
EPS$0.18Beat by $0.02
Revenue estimate$1.4B
EPS estimate$0.16

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$1.4B
EPS estimate$0.21

Financials

Q3 2025

Income statement

See full
Revenue$1.3B+7.1%
Operating income$95.0M+121%
Net income-$28.0M-800%
EPS (diluted)-$0.08-900%

Balance sheet

See full
Cash & equivalents$332.0M-5.1%
Total debt$5.0B+6.9%
Total equity$6.4B-2.4%
Total assets$13.8B+2.3%

Cash flow

See full
Operating cash flow$137.0M-11.0%
CapEx$74.0M+23.3%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$5.33B-21.4%
Enterprise value$9.95B-10.1%
P/S1.1×-0.4×

Profitability

See full
Operating margin1.8%-0.9pp
Net margin-6.1%-1.1pp

Returns & leverage

See full
Return on equity-4.7%-0.6pp
Debt / equity0.8×+0.1×
Current ratio1.5×-0.1×

Segments

By segment

See full
Vision Care$736.0M+7.6%
Pharmaceuticals$280.0M+13.4%
Surgical$215.0M+4.4%

By product

See full
Devices$484.0M+6.4%
OTC$454.0M+8.1%
Branded and Other Generics$59.0M-15.7%

FAQ

When did Bausch + Lomb report Q3 2025 earnings?
Bausch + Lomb (BLCO) reported Q3 2025 earnings on October 29, 2025 before market open.
What were Bausch + Lomb's Q3 2025 revenue and EPS?
Bausch + Lomb reported revenue of $1.3B and eps of $0.18 for Q3 2025.
Did Bausch + Lomb beat estimates in Q3 2025?
Revenue missed the consensus estimate of $1.4B by $102.4M. EPS beat the consensus estimate of $0.16 by $0.02.
How did Bausch + Lomb's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.1% from $1.2B a year earlier and eps grew 5.9% from $0.17.
Where can I find Bausch + Lomb's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001860742-25-000021) and the 10-Q periodic report (0001860742-25-000023) directly on SEC EDGAR. The filing index links above go to sec.gov.